Univen Capital
VC Fund
Univen Capital is a VC fund focused on Sports and Software. Univen Capital created with the aim of contributing to generate a sustainable industrial base in its scope, through participation in high technology companies, based on knowledge and growth potential above average in their sector. Their main objective is to obtain profitability by creating value in investee companies. To do this, they provide themin addition to the required volume of financing, continued support in the management and strategic direction of the company.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Univen Capital invests in
Stages Univen Capital invests in
Countries Univen Capital invests in
Round sizes
Round size
- Seed
- $885k–$1.6M
Investment Focus
Industry
- Sports 1 (33%)
- Software 1 (33%)
- Biopharma 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HUMANoX
|
UMANOX is the only platform in the world that allows you to know the health data of your son or daughter while playing soccer. Because health comes first, the smart connected carbon fiber HX50 shin guards transmit more than 40 metrics in real-time to the HUMANOX platform. | $1.8M / Seed / Sep 08, 2020 | |
Sicubo
|
Sicubo SL is a company formed by professionals who are specially qualified in the field of information technology, development and implementation.Its aim is to build software solutions to optimize the performance of small-and medium-sized (SMEs), particularly in the field of document management.On the occasion of the new rules promoted bythe government to achieve the strategic goal of "zero paper" Sicubo has focused its efforts on designing solutions to digitize, archive and account (if necessary) all paper documents that pass daily by a company (invoices, payroll records, official forms, bank documents, policies and records several). | $885K / Seed / Sep 26, 2007 | |
Bionaturis
|
Bionaturis is a private-owned specialty biopharmaceutical company that develops and manufactures a new generation of biopharmaceutical products using its proprietary FLYLIFE technology. FLYLIFE means the way to get profits from generally considered unprofitable market segments, reducing dramatically up-front capital investments and time-to-market. | Seed / Sep 26, 2007 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Univen Capital invest in?
Univen Capital invests primarily in Sports, Software and Biopharma startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Univen Capital's check size?
Univen Capital typically joins rounds of $885k–$1.6M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Univen Capital participates in.
When did Univen Capital last invest?
The most recent investment recorded for Univen Capital closed in Sep 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
